Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Macrogenics (NQ: MGNX )

16.23 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 16.23
Bid (Size) 14.76 (1)
Ask (Size) 16.78 (1)
Prev. Close 16.23
Today's Range 16.23 - 16.23
52wk Range 4.290 - 21.88
Shares Outstanding 61,107,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with... 
Via Benzinga
MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate
Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resistant prostate cancer (mCRPC). Safety and preliminary efficacy data anticipated... 
Via Benzinga

Performance

YTD
+59.43%
+59.43%
1 Month
+12.63%
+12.63%
3 Month
+35.14%
+35.14%
6 Month
+227.22%
+227.22%
1 Year
+142.24%
+142.24%

More News

Read More
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The Latest Analyst Ratings For Macrogenics
Via Benzinga
MacroGenics Inc. (NASDAQ: MGNX) Leading the Way in Thursday Trading Based on Percentage Gain
Via Investor Brand Network
Macrogenics: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
A Preview Of Macrogenics's Earnings
Via Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 3/5
Via Investor Brand Network
Analyst Expectations For Macrogenics's Future
Via Benzinga
MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Decoding 4 Analyst Evaluations For Macrogenics
Via Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/12
Via Investor Brand Network
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/6
Via Investor Brand Network
Earnings Scheduled For March 7, 2024
Via Benzinga
MicroMarvel MacroGenics Confuses Wall Street
Via Talk Markets
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.